Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 11/12/2025DeliNova Raises CNY 60M in Seed and Angel Financing to Advance In Vivo...
  • 11/12/2025Brightintel Secures Multi-Million CNY Series Pre-A Funding to Advance ...
  • 11/11/2025CDE Seeks Feedbacks on Clinical Trial Guidelines for Adhesion and Irri...
  • 11/11/2025CDE Issues Technical Guidelines for Pharmaceutical Research and Evalua...
  • 11/11/2025CDE Solicits Comments on Revised HPV Vaccine Clinical Trial Guidelines
  • 11/11/2025CDE Reopens Consultation on Influenza Vaccine Clinical Trial Guideline...
  • 11/11/2025CDE Opens Public Consultation on Draft Guidelines for Recombinant Mono...
  • 11/11/2025Chinese Innovative Drug Companies Report Strong Q3 Results
  • 11/11/2025Zydus Receives China NMPA Approval for Venlafaxine ER Capsules
  • 11/11/2025China Launches National Strategy to Integrate AI Across Healthcare Sys...
  • 11/11/2025Simcere to Manufacture Idorsia's Insomnia Drug in China
  • 11/11/2025Glenmark Gains NMPA Approval for RYALTRIS®
  • 11/11/20253SBio Presents Encouraging Phase 2 Results for SSGJ‑707 at SITC 2025
  • 11/11/2025China Approves CPEB's Pediatric CAR‑T Therapy for r/r B‑ALL
  • 11/11/2025Nona and Umoja Expand Partnership to Advance In‑Vivo CAR‑T Cell Ther...
  • 11/11/2025Summit and Akeso Report Positive Phase III Results for Ivonescimab at ...
  • 11/11/2025SanegeneBio and Eli Lilly Form RNAi Collaboration in Metabolic Disease...
  • 11/11/2025Innovent and SanegeneBio Present Positive Phase 1 Data for siRNA Thera...
  • 11/11/2025Huahui to Present 48-Week Phase 2b Data of Libevitug at AASLD 2025
  • 11/11/2025MeiraGTx and Eli Lilly Form Strategic Partnership to Advance Gene Ther...
  • 11/11/2025AZ's Evinova and Harbour BioMed Form AI Partnership to Advance Biologi...
  • 11/7/2025Recent Executive Moves
  • 11/7/2025NMPA Pilots Streamlined Review Pathway for Supplemental Applications o...
  • 11/7/2025UniXell Secures CNY 100M in Series A+ Financing to Advance Stem Cell ...
  • 11/7/2025Vigonvita Life Sciences Debuts on HKSE
  • 11/7/2025Lepu to Present Promising Phase II Data of CD20 ADC MRG001 Plus Orelab...
  • 11/7/2025CARsgen Reports Positive Results for Allogeneic CAR-T Therapies CT0596...
  • 11/7/2025Sanofi's Cablivi Wins Approval in China as First Nanobody Therapy for ...
  • 11/7/2025Correctseq Reports World's First Gene-Editing Treatment for Hyperlipid...
  • 11/6/2025Innorna Reportedly Targets $200M Hong Kong IPO to Accelerate Drug Deve...
  • Page:6/58 Total number of articles:1730: [First][<<] [4] [5] [6] [7] [8] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group